聚甲基丙烯酸甲酯（Artecoll）作为面部重建的辅助手段2聚甲基丙烯酸甲酯（Artecoll）作为面部重建的辅助手段2聚甲基丙烯酸甲酯（Artecoll）作为面部重建的辅助手段2聚甲基丙烯酸甲酯（Artecoll）作为面部重建的辅助手段2聚甲基丙烯酸甲酯（Artecoll）作为面部重建的辅助手段2
At week 24, mean improvement in WSRS from baseline was 2.09 0.68 for the PLA side and 1.54 0.65 for the HA side. Both injections were well toler- ated, and the adverse reactions were mild and transient in most cases. PLA provides noninferior efficac
PLLA-induced augmentation is most likely based on capsule formation orchestrating macrophages, (myo-)fibroblasts, and collagen type I and III fibres. We observed considerably slower degradation of PLLA particles than described previously. Thus PLLA partic
Important lessons have been learned in the use of injectable PLLA that have helped reduce the frequency of adverse events and make it desirable for restoring facial volume (Table 1). The importance of diffuse distribution of the injectable PLLA suspension